$MENS

$1.77 +$0.00 (0.0%) Close

$MENS Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 76.0M shares outstanding

Who owns MENS?

By type of holder

Institutions 0.6% Insiders 33.4% Everyone else 66.0%

Concentration Top 10 holders own 67.3%

Perfect Minds Co., Ltd 33.3% · Kuo Fu-Feng 33.3%

Institutional ownership

0.6%

0.0 pts vs last qtr

Institutional holders

+2 vs last qtr

Net shares bought

+34.4K

by institutions in Q2 2026

New / sold out

5 / 3

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

HRT Financial LP +38.7K
XTX Topco Ltd NEW +29.1K

Biggest sellers in Q2 2026

UBS Group AG −33.3K
Millennium Management LLC SOLD OUT −14.6K

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Jyong Biotech Ltd in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2023–FY2025

+2.0%

+1.00% a year

Each share's claim on the business

−2.0%

shrank without buying or selling a share

Diluted shares, split-adjusted

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years0% 1–3 years0% Under 1 year100%

Quarterly turnover

20.4%

of institutional shares changed hands

Top 10 managers, median time held

2 quarters

Super Investors

Investment managers reporting MENS on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
B BlackRock, Inc.	260.3K	0.34%	+1.6K (+0.6%)	Q4 '25	0.0%
Shares held by quarter Peak holding260.8K (Q4'25) Change over 8 quarters+260.3K Share of the company0.340% BlackRock, Inc.'s full portfolio →
GC Geode Capital Management, LLC	68.9K	0.09%	+4.7K (+7.2%)	Q3 '25	0.0%
Shares held by quarter Peak holding68.9K (Q2'26) Change over 8 quarters+68.9K Share of the company0.090% Geode Capital Management, LLC's full portfolio →

BlackRock, Inc.

260.3K

% of company

0.34%

Change vs last qtr

+1.6K (+0.6%)

Held since

Q4 '25

Geode Capital Management, LLC

68.9K

% of company

0.09%

Change vs last qtr

+4.7K (+7.2%)

Held since

Q3 '25

20 more super investors behind a free account

See every manager holding Jyong Biotech Ltd, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting MENS on Form N-PORT; together they hold 0.0% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
IN Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II	$8.63K	3.9K	0.01%	0.01%	May 31, 2026

Invesco Nasdaq Biotechnology ETF

Invesco Exchange-Traded Fund Trust II

Position value

$8.63K

% of company

0.01%

% of the fund

0.01%

As of

May 31, 2026

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
PM Perfect Minds Co., Ltd 5%+ holder 13D · 33.3%	25.3M	33.34%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company33.340% Disclosed stake13D · 33.3% View the 13D/G filing →
KF Kuo Fu-Feng Insider	25.3M	33.34%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company33.340% Kuo Fu-Feng's insider activity →

Perfect Minds Co., Ltd

5%+ holder13D · 33.3%

25.3M

% of company

33.34%

Change vs last qtr

—

Held since

—

Kuo Fu-Feng

Insider

25.3M

% of company

33.34%

Change vs last qtr

—

Held since

—

2 more holders behind a free account

See every insider and 5%+ holder of Jyong Biotech Ltd.

Comments